AngioDynamics (ANGO) vs STAAR Surgical (STAA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AngioDynamics (ANGO) has outperformed STAAR Surgical (STAA) over the past year, gaining 28.4% versus a loss of 16.3%. Over five years, ANGO leads with a -48.2% price change compared with -80.5% for STAA. STAAR Surgical is the larger company by market cap ($1.12 billion vs $596.8 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | STAA |
|---|---|---|
| Share price | $14.19 | $22.36 |
| Market cap | $596.75M | $1.12B |
| 1-day change | -1.60% | +0.95% |
| YTD return | +10.51% | -3.16% |
| 1-year return | +28.42% | -16.32% |
| 5-year return | -48.15% | -80.54% |
| P/E ratio (TTM) | — | 279.50 |
| Forward P/E | — | 20.12 |
| EPS (TTM) | $-0.88 | $0.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.29 | $35.87 |
| 52-week low | $9.39 | $15.59 |
| Distance from 52-week high | -12.89% | -37.66% |
| Analyst consensus | none | buy |
| Avg. price target upside | +40.94% | +25.22% |
| Average volume | 506.32K | 1.00M |
| Shares outstanding | 42.05M | 50.14M |
| Employees | 632 | 921 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANGO has outperformed STAA by 44.7 percentage points over the past year.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About STAAR Surgical
STAA stock →STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Healthcare · Medical Instruments & Supplies · 921 employees
ANGO vs STAA FAQ
Which is bigger, AngioDynamics or STAAR Surgical?
STAAR Surgical (STAA) is larger, with a market capitalization of $1.12B compared with $596.75M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or STAA?
ANGO returned +28.42% over the past 12 months, compared with -16.32% for STAA (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and STAAR Surgical in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.